Decent Biotech
Decent Biotech, a leading name in the biotechnology sector, is headquartered in China (CN) and operates extensively across Asia and beyond. Founded in 2015, the company has rapidly established itself as a pioneer in developing innovative biopharmaceuticals and advanced therapeutic solutions. Specialising in cutting-edge gene editing and regenerative medicine, Decent Biotech's unique approach combines state-of-the-art technology with a commitment to improving patient outcomes. The company has achieved significant milestones, including successful clinical trials and partnerships with renowned research institutions, solidifying its position in the competitive biotech landscape. With a focus on delivering high-quality, effective treatments, Decent Biotech continues to push the boundaries of science, making notable contributions to the healthcare industry and enhancing its reputation as a trusted leader in biotechnology.
DitchCarbon Score
How does Decent Biotech's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Decent Biotech's score of 0 is lower than 70% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Decent Biotech's reported carbon emissions
Decent Biotech, headquartered in CN, currently does not have available carbon emissions data for recent years, as no specific figures have been provided. Consequently, there are no reported emissions in terms of Scope 1, 2, or 3. Additionally, the company has not outlined any formal reduction targets or commitments to the Science Based Targets initiative (SBTi) or other climate pledges. In the absence of specific emissions data and reduction initiatives, it is essential to note that many companies in the biotech sector are increasingly focusing on sustainability and carbon neutrality. This trend reflects a broader industry commitment to addressing climate change and reducing environmental impact. Decent Biotech may be expected to align with these industry standards in the future.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Decent Biotech is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
